19 results
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
with specificity the nature of such failure, refusal or neglect; or (vi) willful, material breach of any of our material policies or any material provision
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
of or other lien on any Company Intellectual Property or (ii) would affect the proprietary nature of any Company Intellectual Property or restrict … of the nature contemplated by Section 6(a)(ii) effected without its written consent if (i) such settlement is entered into more than 45 days after
S-3
EX-4.3
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
such covenant or condition;
(b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
8-K
EX-10.1
n0ue5
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
10-Q
so6xi dfapegbfgrxd
15 May 23
Quarterly report
5:25pm
DRS/A
6tqa8y
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
snm ojjae6s
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
EX-10.9
toplcr b32i
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.5
z3mni
4 Nov 22
Draft registration statement
12:00am
DRS
uzi83o
4 Nov 22
Draft registration statement
12:00am
DRS
EX-3.1
jp8oi shwe
4 Nov 22
Draft registration statement
12:00am
DRS
EX-3.2
opr y94si5
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.7
aqwxu101
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.6
krv5l9 vwq7gy
4 Nov 22
Draft registration statement
12:00am
D
54zw1eutw
13 Jun 22
$118M in equity, sold $118M, 23 investors
11:57am
- Prev
- 1
- Next